Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Cancer Research

• Publication date

  1983-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 6601984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood in a Haab Stria

  2018cited by this paper
• Clonal analysis of expression of tumor-associated transplantation antigens and of metastatic capacity

  2004cited by this paper
• Lymphoma cell interaction with cultured vascular endothelial cells and with the subendothelial basal lamina: attachment, invasion and morphological appearance.

  1983influential reference
• Metastatic tumor cell attachment and invasion assay utilizing vascular endothelial cell monolayers.

  1982cited by this paper
• Tumor cell attachment to the vascular endothelium and subsequent degradation of the subendothelial extracellular matrix.

  1982influential reference
• Solubilization and degradation of subendothelial matrix glycoproteins and proteoglycans by metastatic tumor cells.

  1982influential reference
• Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant

  1982cited by this paper
• Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

  1981cited by this paper
• Glycosaminoglycan synthesis and composition in human fibroblasts during in vitro cellular aging (IMR‐90)

  1981cited by this paper
• The production and localization of laminin in cultured vascular and corneal endothelial cells

  1981cited by this paper
• Invasion of an artificial blood vessel wall by human fibrosarcoma cells.

  1981cited by this paper
• Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes

  1981cited by this paper
• Cancer Invasion and Metastasis

  1980cited by this paper
• Invasion of endothelial cell monolayers on collagen gels by cells from mammary tumor spheroids.

  1980cited by this paper
• The pathogenesis of cancer metastasis

  1980cited by this paper
• Metastatic potential correlates with enzymatic degradation of basement membrane collagen

  1980cited by this paper
• Isolation of a heparan sulfate-containing proteoglycan from basement membrane.

  1980cited by this paper
• Hepatocyte-tumor cell interaction in vitro. I. Conditions for rosette formation and inhibition by anti-H-2 antibody

  1980influential reference
• Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells.

  1980cited by this paper
• Permissive effect of the extracellular matrix on cell proliferation in vitro.

  1980cited by this paper
• Morphological appearance, growth behavior and migratory activity of human tumor cells maintained on extracellular matrix versus plastic.

  1980cited by this paper
• Metastatic tumor cells adhere preferentially to the extracellular matrix underlying vascular endothelial cells

  1980cited by this paper
• Conditioned medium from endothelial cell cultures can restore the normal phenotypic expression of vascular endothelium maintained in vitro in the absence of fibroblast growth factor

  1980cited by this paper
• Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VII. Interaction of metastasizing and nonmetastasizing tumors with normal tissue in vitro.

  1980cited by this paper
• Biochemistry and metabolism of basement membranes.

  1979cited by this paper
• Structural and functional alterations in the surface of vascular endothelial cells associated with the formation of a confluent cell monolayer and with the withdrawal of fibroblast growth factor.

  1979cited by this paper
• Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo

  1979cited by this paper
• Interactions of tumor cells with vascular endothelial cell monolayers: a model for metastatic invasion.

  1979cited by this paper
• Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice.: Iv. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes

  1979cited by this paper
• Purification of the fibroblast growth factor activity from bovine brain.

  1978cited by this paper
• Stimulation of corneal endothelial cell proliferations in vitro by fibroblast and epidermal growth factors.

  1977cited by this paper
• Etude ultrastructurale sur la pathogénie de l'invasion du muscle strié par des tumeurs transplantables

  1976cited by this paper
• Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent.

  1976influential reference
• [Ultrastructural study on the pathogenesis of transplantable tumor invasion of striated muscle].

  1976cited by this paper
• Possible contribution of basement membrane to the structural rigidity of blood capillaries.

  1975cited by this paper
• A novel assay for the biosynthesis of sulphated polysaccharide and its application to studies on the effects of somatomedin on cultured cells.

  1973cited by this paper
• Biosynthesis of heparin. II. Formation of sulfamino groups.

  1973cited by this paper
• [7] Isolation and characterization of connective tissue polysaccharides

  1972cited by this paper
• A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulphate.

  1971influential reference
• Reaction of heparitin sulfate with nitrous acid

  1968cited by this paper

• Design of Paromomycin and Neomycin as Sulfated and Hydrophobic Glycans to Target Heparanase-Driven Tumor Progression and Metastasis.

  2025cites this paper
• Heparanase as a therapeutic target for mitigating cancer progression.

  2025cites this paper
• Heparanase contributes to pancreatic carcinoma progression through insulin-dependent glucose uptake

  2023cites this paper
• Heparanase—A single protein with multiple enzymatic and nonenzymatic functions

  2023cites this paper
• Molecular Basis for Inhibition of Heparanases and β-Glucuronidases by Siastatin B

  2023cites this paper
• Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo

  2022cites this paper
• Computational design and experimental characterisation of a stable human heparanase variant

  2022cites this paper
• Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer

  2021cites this paper
• New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis

  2021cites this paper
• Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer

  2021cites this paper
• Opposing Effects of Heparanase and Heparanase-2 in Head & Neck Cancer.

  2020cites this paper
• An Overview of the Structure, Mechanism and Specificity of Human Heparanase.

  2020cites this paper
• Immunomodulatory Activities of the Heparan Sulfate Mimetic PG545.

  2020cites this paper
• Heparanase-The Message Comes in Different Flavors.

  2020cites this paper
• Significance of host heparanase in promoting tumor growth and metastasis.

  2020cites this paper
• Correlation between heparanase gene polymorphism and susceptibility to endometrial cancer

  2020cites this paper
• Modulating Heparanase Activity: Tuning Sulfation Pattern and Glycosidic Linkage of Oligosaccharides.

  2020cites this paper
• Forty Years of Basic and Translational Heparanase Research

  2020cites this paper
• Non-Anticoagulant Heparins as Heparanase Inhibitors

  2020influential citation
• Heparanase: Historical Aspects and Future Perspectives.

  2020cites this paper
• Role of Heparanase in tumor progression: molecular aspects and therapeutic options.

  2020cites this paper
• The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.

  2019cites this paper
• The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard

  2018cites this paper
• Specific Inhibition of Heparanase by a Glycopolymer with Well-Defined Sulfation Pattern Prevents Breast Cancer Metastasis in Mice.

  2018cites this paper
• POLYNUCLEOTIDE ENCODING A POLYPEPTIDE HAVING HEPARANASE ACTIVITY AND EXPRESSION OF SAME IN GENETICALLY MODIFIED CELLS

  2017cites this paper
• United States Patent ( 10 ) Patent No . : US 6 , 531 , 129 B 2

  2017influential citation
• Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data

  2017cites this paper
• Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases.

  2016cites this paper
• The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas.

  2016cites this paper
• Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis

  2016cites this paper
• Heparanase augments insulin receptor signaling in breast carcinoma

  2016cites this paper
• Heparanase is required for activation and function of macrophages

  2016cites this paper
• Novel Regulators of Brain Tumor Development : – From neural stem cell differentiation to in vivo models

  2015cites this paper
• Recent data concerning heparanase: focus on fibrosis, inflammation and cancer

  2015cites this paper
• Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: Effect on P-selectin, heparanase, metastasis and cellular recruitment.

  2015cites this paper
• Heparanase is involved in proliferation and invasion of ovarian cancer cells

  2015cites this paper
• Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition

  2014cites this paper
• Role of Heparanase-Driven Inflammatory Cascade in Pathogenesis of Diabetic Nephropathy

  2014cites this paper
• Heparanase, a potential marker for premalignant oral cavity cancer.

  2014cites this paper
• Heparanase as a target in cancer therapy.

  2014cites this paper
• BREAST CANCER METASTATIC DORMANCY AND EMERGENCE IN THE HEPATIC NICHE

  2013influential citation
• Heparanase in inflammation and inflammation‐associated cancer

  2013cites this paper
• Heparanase is involved in the proliferation and invasion of nasopharyngeal carcinoma cells.

  2013cites this paper
• Versatile role of heparanase in inflammation.

  2013cites this paper
• Significance of Heparanase in Cancer and Inflammation

  2012cites this paper
• Dissociation between Mature Phenotype and Impaired Transmigration in Dendritic Cells from Heparanase-Deficient Mice

  2012cites this paper
• Heparanase enzyme in chronic inflammatory bowel disease and colon cancer

  2012cites this paper
• Role of heparanase in radiation-enhanced invasiveness of pancreatic carcinoma.

  2011cites this paper
• Impact of Heparanase and the Tumor Microenvironment on Cancer Metastasis and Angiogenesis: Basic Aspects and Clinical Applications

  2011cites this paper
• Pancreatic Carcinoma Role of Heparanase in Radiation-Enhanced Invasiveness of Updated

  2011cites this paper
• Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice.

  2011cites this paper
• Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase.

  2011cites this paper
• Cancer Therapy : Preclinical SST 0001 , a Chemically Modified Heparin , Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase / Syndecan-1 Axis

  2011cites this paper
• SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis

  2011cites this paper
• Heparanase enhances nerve-growth-factor-induced PC12 cell neuritogenesis via the p38 MAPK pathway.

  2011cites this paper
• Heparanase 2 Interacts with Heparan Sulfate with High Affinity and Inhibits Heparanase Activity*

  2010cites this paper
• Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis

  2010cites this paper
• Tumorigenic and adhesive properties of heparanase.

  2010cites this paper
• Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening.

  2010cites this paper
• A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics

  2010cites this paper
• Heparanase drives the aggressive myeloma phenotype: Preclinical development of a heparanase inhibitor for the treatment of multiple myeloma

  2010cites this paper
• Newly Generated Heparanase Knock-Out Mice Unravel Co-Regulation of Heparanase and Matrix Metalloproteinases

  2009cites this paper
• PLASMA HEPARANASE AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN CHILDREN WITH HODGKIN LYMPHOMA: Pilot Study

  2009cites this paper
• Marine-derived oligosaccharide sulfate (JG3) suppresses heparanase-driven cell adhesion events in heparanase over-expressing CHO-K1 cells

  2009cites this paper
• Alternatively spliced Spalax heparanase inhibits extracellular matrix degradation, tumor growth, and metastasis

  2009cites this paper
• Structure-function approach identifies a COOH-terminal domain that mediates heparanase signaling.

  2009cites this paper
• TUNEL as a tumor marker of tongue cancer.

  2008cites this paper
• TUNEL as aTumor Marker ofTongue Cancer

  2008cites this paper
• Cathepsin L Is Responsible for Processing and Activation of Proheparanase through Multiple Cleavages of a Linker Segment*

  2008cites this paper
• Heparanase induces VEGF C and facilitates tumor lymphangiogenesis

  2008cites this paper
• Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma

  2008cites this paper
• Function of Heparanase in Prostate Tumorigenesis: Potential for Therapy

  2008cites this paper
• Molecular and Cellular Aspects of Heparanase

  2008cites this paper
• Heparanase Facilitates Cell Adhesion and Spreading by Clustering of Cell Surface Heparan Sulfate Proteoglycans

  2008cites this paper
• Tamoxifen Induces Heparanase Expression in Estrogen Receptor–Positive Breast Cancer

  2007cites this paper
• Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.

  2007cites this paper
• The Development of a Diagnostic Test for Heparanase Activity

  2007cites this paper
• Award Number: W81XWH-04-1-0235 TITLE: Involvement and Regulation of Heparanase in Prostate Cancer Progression PRINCIPAL INVESTIGATOR: Dr. Michael Elkin CONTRACTING ORGANIZATION: Hadassah Medical Organization

  2007influential citation
• Role of heparanase and heparanase-degraded heparan sulfate in brain-metastatic melanoma

  2007cites this paper
• Heparanase up‐regulation in tongue cancer

  2007cites this paper
• Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment.

  2007cites this paper
• Heparanase upregulation by colonic epithelium in inflammatory bowel disease

  2007cites this paper
• Cloning, expression, and characterization of an alternatively spliced variant of human heparanase.

  2007cites this paper
• Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.

  2006cites this paper
• Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.

  2006cites this paper
• Heparanase promotes growth, angiogenesis and survival of primary breast tumors

  2006cites this paper
• Dendritic Cells Monocyte-Derived Transmigration of Mature Extracellular Matrix Heparan Sulfate upon Surface Regulates Degradation of Translocation of Active Heparanase to Cell

  2006cites this paper
• Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival

  2006cites this paper
• Translocation of Active Heparanase to Cell Surface Regulates Degradation of Extracellular Matrix Heparan Sulfate upon Transmigration of Mature Monocyte-Derived Dendritic Cells1

  2006cites this paper
• Heparanase induces tissue factor expression in vascular endothelial and cancer cells

  2006cites this paper
• The Impact of Heparanese and Heparin on Cancer Metastasis and Angiogenesis

  2006cites this paper
• SUGGESTIVE EVIDENCE THAT THE HIGHLY METASTATIC SPONTANEOUS FUSION WITH A HOST MACROPHAGE VARIANT ESb OF THE T-CELL LYMPHOMA Eb IS DERIVED FROM

  2006cites this paper
• Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival.

  2006cites this paper
• Involvement and Regulation of Heparanase in Prostate Cancer Progression

  2006cites this paper
• Development of heparanase inhibitors for anti-cancer therapy.

  2006cites this paper
• Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence

  2006cites this paper
• Tumor suppressor p53 regulates heparanase gene expression

  2006cites this paper
• An ELISA method for the detection and quantification of human heparanase.

  2006cites this paper
• Xanthofibroma of the adrenal gland

  2006cites this paper
• Characterization of Mechanisms Involved in Secretion of Active Heparanase*

  2006cites this paper